Stem cells have become the corner stone of research into providing revolutionary treatments for dry macular degeneration. Continuing its Phase I & Phase II clinical trials, StemCells Inc has transplanted stem cells into its first patient suffering from dry macular degeneration. Macular degeneration is an eye disease more common among people aged 50 and older. According to the National Institute of Health, it is the leading cause of blindness in older adults.
View the original article here: Stem Cells Implanted into Patient with Dry Macular Degeneration …
